Featured Research

from universities, journals, and other organizations

SPECT Provides High-quality Images Of Small Tumors

Date:
June 15, 2009
Source:
Society of Nuclear Medicine
Summary:
A new study shows that combining high resolution and high sensitivity collimation provides better quality images when using single photon emission computed tomography (SPECT) scans.

A new study shows that combining high resolution and high sensitivity collimation provides better quality images when using single photon emission computed tomography (SPECT) scans, said researchers at SNM's 56th Annual Meeting.

Collimators—devices that filter a stream of rays so that only those traveling parallel to a specified direction are allowed through—are used in SPECT because it is not yet possible to focus radiation with such short wavelengths into an image with the use of lenses. Using the two types of collimation in tandem is especially effective for better imaging of small tumors, the study indicates.

"SPECT is an important tool in molecular imaging because of its ability to provide accurate images of what is going on in the body without the need for invasive procedures such as surgery," said Roel Van Holen, researcher in the department of electronics and information systems of Ghent University, Ghent, Belgium, and lead author of the study. "However, researchers have had to make tradeoffs in SPECT image quality, especially in imaging very small tumors. Our research is exciting because it shows that combining high-resolution and high-energy collimators can improve SPECT's ability to image small tumors."

Researchers have established that SPECT image quality generally improves when using collimators with higher sensitivity than traditional low-energy high-resolution (LEHR) collimators. However, this is not the case when small tumors are being imaged. In these cases, LEHR actually provides better images.

The new study combined a high-resolution collimator with a high-sensitivity collimator. A dual-head SPECT camera with three different collimator settings was simulated using the GATE Monte Carlo simulator. The results indicated that SPECT image quality was better with the mixed collimation than it was by using only high-resolution or only high-sensitivity collimation.


Story Source:

The above story is based on materials provided by Society of Nuclear Medicine. Note: Materials may be edited for content and length.


Cite This Page:

Society of Nuclear Medicine. "SPECT Provides High-quality Images Of Small Tumors." ScienceDaily. ScienceDaily, 15 June 2009. <www.sciencedaily.com/releases/2009/06/090615144327.htm>.
Society of Nuclear Medicine. (2009, June 15). SPECT Provides High-quality Images Of Small Tumors. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2009/06/090615144327.htm
Society of Nuclear Medicine. "SPECT Provides High-quality Images Of Small Tumors." ScienceDaily. www.sciencedaily.com/releases/2009/06/090615144327.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins